Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection

• Conditions: Disorder of Transplanted Kidney; Cytomegalovirus Infections

• Registration Number: NCT01353053
• Lead Sponsor: Federal University of São Paulo

Brief Summary

The aim of this the study is to the assess whether the graft and patient survival, rejection rates and renal graft function after the first year will not differ between both study arms. The investigators will also the evaluate the reduction in the incidence of cytomegalovirus the and improvement of renal function of the everolimus after 1 year.

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-05
• Study Start: 2010-07
• Study First Submitted: 2011-05-11
• Study First Submitted QC: 2011-05-11
• Last Update Submitted: 2011-05-11
• Study First Posted: 2011-05-12
• Last Update Posted: 2011-05-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

• Patients with BMI below 30,
• first transplants with PRA < 30,
• no contraindication for induction Thymoglobuline,
• age 18 years or younger than 70 years.

Exclusion Criteria

• patients with a BMI above 30
• retransplantation
• patients hypersensitized with PRA > 30
• compared with Thymoglobulina indication for induction
• age under 18 or over 70 years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Hospital Israelita Albert Einstein; 🇧🇷 Sao Paulo, SP, Brazil